The mechanism(s) by which BET inhibition ameliorates CS-induced DD remains a mystery, and we are left to assume that, in COVID-19 patients, BRD4 is activated upon phosphorylation to stimulate pathological gene expression that results in cardiac relaxation impairment [Figure 1]. This evidence concerns the gene BRD4 and COVID-19.